Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4354345 | Trends in Neurosciences | 2011 | 10 Pages |
Abstract
Death receptors (DRs) are members of the tumor necrosis factor receptor (TNF-R) superfamily that are characterised by the presence of a conserved intracellular death domain and are able to trigger a signalling pathway leading to apoptosis. Strong evidence suggests that DRs contribute to the pathology of tissue destructive diseases, including multiple sclerosis (MS), the most common inflammatory demyelinating disease of the central nervous system (CNS). Here, we review the evidence supporting a role for DRs in MS pathology and its implications for the development of therapeutic strategies for MS and other demyelinating pathologies of the CNS.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Conor Mc Guire, Rudi Beyaert, Geert van Loo,